# Crane Co: financial statements, quarterly

CR · NYSE · CIK 1944013 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cr.md) · [Financials](/companies/cr/financials.md) · [Filings](/companies/cr/filings.md) · [Insiders](/companies/cr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [484](/filings/0001628280-25-008728.md) | [510](/filings/0001628280-25-021491.md) | [529](/filings/0001628280-25-036977.md) | [548](/filings/0001944013-25-000116.md) | [544](/filings/0001628280-25-008728.md) | [558](/filings/0001944013-26-000161.md) | [577](/filings/0001944013-26-000186.md) | [589](/filings/0001628280-26-068180.md) | [581 d](/filings/0001944013-26-000095.md) | [696](/filings/0001944013-26-000161.md) | [725](/filings/0001944013-26-000186.md) | [755](/filings/0001628280-26-068180.md) |
| Cost of revenue | $m | [300](/filings/0001628280-25-008728.md) | [303](/filings/0001628280-25-021491.md) | [317](/filings/0001628280-25-036977.md) | [321](/filings/0001944013-25-000116.md) | [322](/filings/0001628280-25-008728.md) | [320](/filings/0001944013-26-000161.md) | [335](/filings/0001944013-26-000186.md) | [338](/filings/0001628280-26-068180.md) | [339 d](/filings/0001944013-26-000095.md) | [415](/filings/0001944013-26-000161.md) | [417](/filings/0001944013-26-000186.md) | [440](/filings/0001628280-26-068180.md) |
| Gross profit | $m | [184](/filings/0001628280-25-008728.md) | [207](/filings/0001628280-25-008728.md) | [212](/filings/0001628280-25-008728.md) | [227](/filings/0001628280-25-008728.md) | [223](/filings/0001628280-25-008728.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [106 d](/filings/0001628280-25-008728.md) | [126](/filings/0001628280-25-021491.md) | [127](/filings/0001628280-24-033745.md) | [133](/filings/0001628280-24-044560.md) | [121 d](/filings/0001628280-25-008728.md) | [137](/filings/0001628280-25-021491.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [62.4](/filings/0001628280-25-008728.md) | [81.3](/filings/0001628280-25-021491.md) | [89.3](/filings/0001628280-25-036977.md) | [99.0](/filings/0001944013-25-000116.md) | [86.2](/filings/0001628280-25-008728.md) | [101](/filings/0001944013-26-000161.md) | [103](/filings/0001944013-26-000186.md) | [118](/filings/0001628280-26-068180.md) | [102 d](/filings/0001944013-26-000095.md) | [100](/filings/0001944013-26-000161.md) | [144](/filings/0001944013-26-000186.md) | [141](/filings/0001628280-26-068180.md) |
| Interest expense | $m | [6.0 d](/filings/0001628280-24-006915.md) | [7.2](/filings/0001628280-25-021491.md) | [7.4](/filings/0001628280-25-036977.md) | [7.3](/filings/0001944013-25-000116.md) | [5.3 d](/filings/0001944013-26-000095.md) | [4.5](/filings/0001944013-26-000161.md) | [4.3](/filings/0001944013-26-000186.md) | [1.0](/filings/0001628280-26-068180.md) | [1.5 d](/filings/0001944013-26-000095.md) | [16.8](/filings/0001944013-26-000161.md) | [16.6](/filings/0001944013-26-000186.md) | [13.7](/filings/0001628280-26-068180.md) |
| Income tax | $m | [8.7 d](/filings/0001944013-26-000095.md) | [15.3](/filings/0001628280-25-021491.md) | [18.2](/filings/0001628280-25-036977.md) | [21.2](/filings/0001944013-25-000116.md) | [15.6 d](/filings/0001944013-26-000095.md) | [20.5](/filings/0001944013-26-000161.md) | [24.3](/filings/0001944013-26-000186.md) | [29.0](/filings/0001628280-26-068180.md) | [27.3 d](/filings/0001944013-26-000095.md) | [18.0](/filings/0001944013-26-000161.md) | [32.1](/filings/0001944013-26-000186.md) | [28.9](/filings/0001628280-26-068180.md) |
| Net income | $m | [49.4](/filings/0001628280-25-008728.md) | [64.8](/filings/0001628280-25-021491.md) | [71.6](/filings/0001628280-25-036977.md) | [77.3](/filings/0001944013-25-000116.md) | [81.0](/filings/0001628280-25-008728.md) | [107](/filings/0001944013-26-000161.md) | [86.4](/filings/0001944013-26-000186.md) | [91.4](/filings/0001628280-26-068180.md) | [81.7 d](/filings/0001944013-26-000095.md) | [67.1](/filings/0001944013-26-000161.md) | [95.9](/filings/0001944013-26-000186.md) | [97.3](/filings/0001628280-26-068180.md) |
| Diluted EPS | $ per share | [0.86](/filings/0001628280-25-008728.md) | [1.12](/filings/0001628280-25-021491.md) | [1.23](/filings/0001628280-25-036977.md) | [1.33](/filings/0001944013-25-000116.md) | [1.38](/filings/0001628280-25-008728.md) | [1.83](/filings/0001944013-26-000161.md) | [1.47](/filings/0001944013-26-000186.md) | [1.56](/filings/0001628280-26-068180.md) | not reported | [1.14](/filings/0001944013-26-000161.md) | [1.63](/filings/0001944013-26-000186.md) | [1.66](/filings/0001628280-26-068180.md) |
| Basic EPS | $ per share | [0.87](/filings/0001628280-25-008728.md) | [1.14](/filings/0001628280-25-021491.md) | [1.25](/filings/0001628280-25-036977.md) | [1.35](/filings/0001944013-25-000116.md) | [1.41](/filings/0001628280-25-008728.md) | [1.86](/filings/0001944013-26-000161.md) | [1.51](/filings/0001944013-26-000186.md) | [1.59](/filings/0001628280-26-068180.md) | not reported | [1.16](/filings/0001944013-26-000161.md) | [1.66](/filings/0001944013-26-000186.md) | [1.68](/filings/0001628280-26-068180.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [330](/filings/0001944013-26-000095.md) | [219](/filings/0001628280-24-019638.md) | [229](/filings/0001628280-24-033745.md) | [258](/filings/0001628280-24-044560.md) | [307](/filings/0001944013-26-000095.md) | [435](/filings/0001628280-25-021491.md) | [332](/filings/0001628280-25-036977.md) | [388](/filings/0001944013-25-000116.md) | [507](/filings/0001628280-26-068180.md) | [355](/filings/0001944013-26-000161.md) | [350](/filings/0001944013-26-000186.md) | [316](/filings/0001628280-26-068180.md) |
| Current assets | $m | [1,091](/filings/0001628280-25-008728.md) | [1,072](/filings/0001628280-24-019638.md) | [1,109](/filings/0001628280-24-033745.md) | [1,245](/filings/0001628280-24-044560.md) | [1,403](/filings/0001944013-26-000095.md) | [1,374](/filings/0001628280-25-021491.md) | [1,246](/filings/0001628280-25-036977.md) | [1,280](/filings/0001944013-25-000116.md) | [2,571](/filings/0001628280-26-068180.md) | [1,482](/filings/0001944013-26-000161.md) | [1,479](/filings/0001944013-26-000186.md) | [1,486](/filings/0001628280-26-068180.md) |
| Total assets | $m | [2,351](/filings/0001628280-25-008728.md) | [2,418](/filings/0001628280-24-019638.md) | [2,507](/filings/0001628280-24-033745.md) | [2,652](/filings/0001628280-24-044560.md) | [2,642](/filings/0001944013-26-000095.md) | [2,622](/filings/0001628280-25-021491.md) | [2,517](/filings/0001628280-25-036977.md) | [2,549](/filings/0001944013-25-000116.md) | [3,853](/filings/0001628280-26-068180.md) | [4,052](/filings/0001944013-26-000161.md) | [4,031](/filings/0001944013-26-000186.md) | [3,996](/filings/0001628280-26-068180.md) |
| Current liabilities | $m | [467](/filings/0001628280-25-008728.md) | [493](/filings/0001628280-24-019638.md) | [521](/filings/0001628280-24-033745.md) | [572](/filings/0001628280-24-044560.md) | [543](/filings/0001944013-26-000095.md) | [660](/filings/0001628280-25-021491.md) | [426](/filings/0001628280-25-036977.md) | [392](/filings/0001944013-25-000116.md) | [465](/filings/0001628280-26-068180.md) | [520](/filings/0001944013-26-000161.md) | [528](/filings/0001944013-26-000186.md) | [568](/filings/0001628280-26-068180.md) |
| Total liabilities | $m | [973](/filings/0001628280-24-044560.md) | [1,011](/filings/0001628280-24-019638.md) | [1,031](/filings/0001628280-24-033745.md) | [1,075](/filings/0001628280-24-044560.md) | [1,001](/filings/0001944013-25-000116.md) | [863](/filings/0001628280-25-021491.md) | [628](/filings/0001628280-25-036977.md) | [581](/filings/0001944013-25-000116.md) | [1,790](/filings/0001628280-26-068180.md) | [1,953](/filings/0001944013-26-000161.md) | [1,851](/filings/0001944013-26-000186.md) | [1,728](/filings/0001628280-26-068180.md) |
| Long-term debt | $m | [249](/filings/0001628280-25-008728.md) | [247](/filings/0001628280-24-019638.md) | [247](/filings/0001628280-24-033745.md) | [247](/filings/0001628280-24-044560.md) | [247](/filings/0001944013-26-000095.md) | [0.0](/filings/0001628280-25-021491.md) | [0.0](/filings/0001628280-25-036977.md) | [0.0](/filings/0001944013-25-000116.md) | [1,148](/filings/0001628280-26-068180.md) | [1,193](/filings/0001944013-26-000161.md) | [1,087](/filings/0001944013-26-000186.md) | [912](/filings/0001628280-26-068180.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-25-036977.md) | [247](/filings/0001628280-25-021491.md) | [47.2](/filings/0001628280-25-036977.md) | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [0.0](/filings/0001628280-24-044560.md) | [110](/filings/0001628280-24-019638.md) | [130](/filings/0001628280-24-033745.md) | [85.0](/filings/0001628280-24-044560.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-068180.md) | [5.6](/filings/0001944013-26-000161.md) | [11.3](/filings/0001944013-26-000186.md) | [16.9](/filings/0001628280-26-068180.md) |
| Shareholders' equity | $m | [1,358](/filings/0001628280-25-008728.md) | [1,405](/filings/0001628280-24-019638.md) | [1,473](/filings/0001628280-24-033745.md) | [1,574](/filings/0001628280-24-044560.md) | [1,639](/filings/0001944013-26-000095.md) | [1,757](/filings/0001628280-25-021491.md) | [1,886](/filings/0001628280-25-036977.md) | [1,966](/filings/0001944013-25-000116.md) | [2,061](/filings/0001628280-26-068180.md) | [2,097](/filings/0001944013-26-000161.md) | [2,178](/filings/0001944013-26-000186.md) | [2,266](/filings/0001628280-26-068180.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [128 d](/filings/0001944013-26-000095.md) | [(70.9)](/filings/0001628280-25-021491.md) | [51.3 d](/filings/0001628280-25-036977.md) | [75.4 d](/filings/0001944013-25-000116.md) | [202 d](/filings/0001944013-26-000095.md) | [(46.2)](/filings/0001944013-26-000161.md) | [105 d](/filings/0001944013-26-000186.md) | [130 d](/filings/0001628280-26-068180.md) | [206 d](/filings/0001944013-26-000095.md) | [(29.5)](/filings/0001944013-26-000161.md) | [122 d](/filings/0001944013-26-000186.md) | [128 d](/filings/0001628280-26-068180.md) |
| Dividends paid | $m | [10.3 d](/filings/0001944013-26-000095.md) | [11.7](/filings/0001628280-25-021491.md) | [11.7 d](/filings/0001628280-25-036977.md) | [11.7 d](/filings/0001944013-25-000116.md) | [11.8 d](/filings/0001944013-26-000095.md) | [13.2](/filings/0001944013-26-000161.md) | [13.2 d](/filings/0001944013-26-000186.md) | [13.3 d](/filings/0001628280-26-068180.md) | [13.2 d](/filings/0001944013-26-000095.md) | [14.7](/filings/0001944013-26-000161.md) | [14.7 d](/filings/0001944013-26-000186.md) | [14.7 d](/filings/0001628280-26-068180.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-006915.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.3](/filings/0001628280-24-019638.md) | [57.4](/filings/0001628280-24-033745.md) | [57.5](/filings/0001628280-24-044560.md) | [58.1](/filings/0001628280-25-021491.md) | [58.3](/filings/0001628280-25-036977.md) | [58.3](/filings/0001944013-25-000116.md) | [58.5](/filings/0001944013-26-000161.md) | [58.5](/filings/0001944013-26-000186.md) | [58.6](/filings/0001628280-26-068180.md) | [58.7](/filings/0001944013-26-000161.md) | [58.7](/filings/0001944013-26-000186.md) | [58.8](/filings/0001628280-26-068180.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 57,833,158 at 2026-10-27, from the cover of the [10-Q filed 2026-10-29](/filings/0001628280-26-068180.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 15:36 ET. No prices; not investment advice.